241 related articles for article (PubMed ID: 29103030)
1. miR-30a-5p together with miR-210-3p as a promising biomarker for non-small cell lung cancer: A preliminary study.
Świtlik W; Karbownik MS; Suwalski M; Kozak J; Szemraj J
Cancer Biomark; 2018 Feb; 21(2):479-488. PubMed ID: 29103030
[TBL] [Abstract][Full Text] [Related]
2. Differential expression profiles of microRNAs as potential biomarkers for the early diagnosis of lung cancer.
Zhang Y; Sui J; Shen X; Li C; Yao W; Hong W; Peng H; Pu Y; Yin L; Liang G
Oncol Rep; 2017 Jun; 37(6):3543-3553. PubMed ID: 28498428
[TBL] [Abstract][Full Text] [Related]
3. Non-small cell lung cancer associated microRNA expression signature: integrated bioinformatics analysis, validation and clinical significance.
Li C; Yin Y; Liu X; Xi X; Xue W; Qu Y
Oncotarget; 2017 Apr; 8(15):24564-24578. PubMed ID: 28445945
[TBL] [Abstract][Full Text] [Related]
4. Serum miR-210-3p as a Potential Noninvasive Biomarker of Lung Adenocarcinoma: A Preliminary Study.
Świtlik WZ; Karbownik MS; Suwalski M; Kozak J; Szemraj J
Genet Test Mol Biomarkers; 2019 May; 23(5):353-358. PubMed ID: 30950648
[No Abstract] [Full Text] [Related]
5. Identification of serum miRNAs by nano-quantum dots microarray as diagnostic biomarkers for early detection of non-small cell lung cancer.
Fan L; Qi H; Teng J; Su B; Chen H; Wang C; Xia Q
Tumour Biol; 2016 Jun; 37(6):7777-84. PubMed ID: 26695145
[TBL] [Abstract][Full Text] [Related]
6. Identification of key microRNAs and hub genes in non-small-cell lung cancer using integrative bioinformatics and functional analyses.
Song F; Xuan Z; Yang X; Ye X; Pan Z; Fang Q
J Cell Biochem; 2020 Mar; 121(3):2690-2703. PubMed ID: 31692035
[TBL] [Abstract][Full Text] [Related]
7. Plasma miR-1247-5p, miR-301b-3p and miR-105-5p as potential biomarkers for early diagnosis of non-small cell lung cancer.
Dong X; Chang M; Song X; Ding S; Xie L; Song X
Thorac Cancer; 2021 Feb; 12(4):539-548. PubMed ID: 33372399
[TBL] [Abstract][Full Text] [Related]
8. Serum miR-1228-3p and miR-181a-5p as Noninvasive Biomarkers for Non-Small Cell Lung Cancer Diagnosis and Prognosis.
Xue WX; Zhang MY; Rui Li ; Liu X; Yin YH; Qu YQ
Biomed Res Int; 2020; 2020():9601876. PubMed ID: 32724822
[TBL] [Abstract][Full Text] [Related]
9. Evaluation of Tumor-Derived Exosomal miRNA as Potential Diagnostic Biomarkers for Early-Stage Non-Small Cell Lung Cancer Using Next-Generation Sequencing.
Jin X; Chen Y; Chen H; Fei S; Chen D; Cai X; Liu L; Lin B; Su H; Zhao L; Su M; Pan H; Shen L; Xie D; Xie C
Clin Cancer Res; 2017 Sep; 23(17):5311-5319. PubMed ID: 28606918
[No Abstract] [Full Text] [Related]
10. Analysis of microRNA (miRNA) expression profiles reveals 11 key biomarkers associated with non-small cell lung cancer.
Wang K; Chen M; Wu W
World J Surg Oncol; 2017 Sep; 15(1):175. PubMed ID: 28927412
[TBL] [Abstract][Full Text] [Related]
11. Meta-signature guided investigation of miRNA candidates as potential biomarkers of oral cancer.
Stojkovic G; Jovanovic I; Dimitrijevic M; Jovanovic J; Tomanovic N; Stankovic A; Arsovic N; Boricic I; Zeljic K
Oral Dis; 2023 May; 29(4):1550-1564. PubMed ID: 35262985
[TBL] [Abstract][Full Text] [Related]
12. Clinical evaluation of microRNA expression profiling in non small cell lung cancer.
Markou A; Sourvinou I; Vorkas PA; Yousef GM; Lianidou E
Lung Cancer; 2013 Sep; 81(3):388-396. PubMed ID: 23756108
[TBL] [Abstract][Full Text] [Related]
13. Differential expression of miR-125a-5p and let-7e predicts the progression and prognosis of non-small cell lung cancer.
Zhu WY; Luo B; An JY; He JY; Chen DD; Xu LY; Huang YY; Liu XG; Le HB; Zhang YK
Cancer Invest; 2014 Oct; 32(8):394-401. PubMed ID: 24945821
[TBL] [Abstract][Full Text] [Related]
14. Circulating miR-21-5p and miR-126-3p: diagnostic, prognostic value, and multivariate analysis in non-small-cell lung cancer.
Soliman SE; Abdelaleem AH; Alhanafy AM; Ibrahem RAL; Elhaded ASA; Assar MFA
Mol Biol Rep; 2021 Mar; 48(3):2543-2552. PubMed ID: 33837901
[TBL] [Abstract][Full Text] [Related]
15. Identification of differentially expressed circulating serum microRNA for the diagnosis and prognosis of Indian non-small cell lung cancer patients.
Kumar S; Sharawat SK; Ali A; Gaur V; Malik PS; Kumar S; Mohan A; Guleria R
Curr Probl Cancer; 2020 Aug; 44(4):100540. PubMed ID: 32007320
[TBL] [Abstract][Full Text] [Related]
16. miR-30a-5p enhances paclitaxel sensitivity in non-small cell lung cancer through targeting BCL-2 expression.
Xu X; Jin S; Ma Y; Fan Z; Yan Z; Li W; Song Q; You W; Lyu Z; Song Y; Shi P; Liu Y; Han X; Li L; Li Y; Liu Y; Ye Q
J Mol Med (Berl); 2017 Aug; 95(8):861-871. PubMed ID: 28487996
[TBL] [Abstract][Full Text] [Related]
17. LncRNA DLEU2 accelerates the tumorigenesis and invasion of non-small cell lung cancer by sponging miR-30a-5p.
Wu W; Zhao Y; Gao E; Li Y; Guo X; Zhao T; He W; Zhang H
J Cell Mol Med; 2020 Jan; 24(1):441-450. PubMed ID: 31721438
[TBL] [Abstract][Full Text] [Related]
18. Down-regulation of microRNA-144-3p and its clinical value in non-small cell lung cancer: a comprehensive analysis based on microarray, miRNA-sequencing, and quantitative real-time PCR data.
Chen YJ; Guo YN; Shi K; Huang HM; Huang SP; Xu WQ; Li ZY; Wei KL; Gan TQ; Chen G
Respir Res; 2019 Mar; 20(1):48. PubMed ID: 30832674
[TBL] [Abstract][Full Text] [Related]
19. Relative expressions of miR-205-5p, miR-205-3p, and miR-21 in tissues and serum of non-small cell lung cancer patients.
Jiang M; Zhang P; Hu G; Xiao Z; Xu F; Zhong T; Huang F; Kuang H; Zhang W
Mol Cell Biochem; 2013 Nov; 383(1-2):67-75. PubMed ID: 23881177
[TBL] [Abstract][Full Text] [Related]
20. MicroRNA-187-5p suppresses cancer cell progression in non-small cell lung cancer (NSCLC) through down-regulation of CYP1B1.
Mao M; Wu Z; Chen J
Biochem Biophys Res Commun; 2016 Sep; 478(2):649-55. PubMed ID: 27495872
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]